Global Non-Animal Softgel Capsules Market Growth 2023-2029

Global Non-Animal Softgel Capsules Market Growth 2023-2029

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
LPI (LP Information)' newest research report, the “Non-Animal Softgel Capsules Industry Forecast” looks at past sales and reviews total world Non-Animal Softgel Capsules sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Animal Softgel Capsules sales for 2023 through 2029. With Non-Animal Softgel Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Animal Softgel Capsules industry.
This Insight Report provides a comprehensive analysis of the global Non-Animal Softgel Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Animal Softgel Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Non-Animal Softgel Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Animal Softgel Capsules and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Animal Softgel Capsules.
The global Non-Animal Softgel Capsules market size is projected to grow from US$ 541 million in 2022 to US$ 895.7 million in 2029; it is expected to grow at a CAGR of 895.7 from 2023 to 2029.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Animal Softgel Capsules market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segmentation by application
Health Supplements
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang

Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Animal Softgel Capsules market?
What factors are driving Non-Animal Softgel Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Animal Softgel Capsules market opportunities vary by end market size?
How does Non-Animal Softgel Capsules break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.